Monthly Archives: October, 2012
News
Quanterix’s Ultrasensitive Simoaâ„¢ Technology Demonstrates Equivalence with NAT and 3,000x Improvem
Quanterix Corporation announced today that the Journal of Virological Methods published a key study describing the application of its ultra-sensitive single-molecule digital immunoassay, Simoa,...
News
A New Video Website From ITN and the Royal Pharmaceutical Society Focuses on Changes in Pharmacy
Healthcare News from ITN Productions and the Royal Pharmaceutical Society (RPS) reveals new solutions in medicines management; how pharmacists can improve patient outcomes while...
News
FDA Inspects MicroConstants for Compliance with Good Laboratory Practices, No Deficiencies Noted
Bioanalytical and pharmacokinetic specialty Contract Research Organization (CRO) MicroConstants announced today the successful completion of a five-day inspection by the United States Food and...
News
Proteonomix, Inc. Announces IRB Approval for Its Clinical Trial of UMK-121 in Patients with End Stag
PROTEONOMIX, INC. , a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced today that the...
News
NeuroGeneration Recruits Top Scientist To Direct New Division of Biotherapeutics and Drug Discovery
senior research neuroscientist from The Salk Institute, Mohamedi Kagalwala PhD, has been recruited to head NeuroGeneration's new laboratories in La Jolla, California. Dr. Kagalwala,...
Press Releases
Datapharm Australia Selects Merge eClinical OS(TM) for Enterprise-Wide Electronic Data Capture
Merge Healthcare Incorporated , a leading provider of clinical systems and innovations that seek to transform healthcare, today announced that Datapharm Australia Pty Ltd....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read